» Articles » PMID: 1900303

Distribution and Comparison of Receptors for Leukemia Inhibitory Factor on Murine Hemopoietic and Hepatic Cells

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 1991 Feb 1
PMID 1900303
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Leukemia inhibitory factor (LIF) is a glycoprotein that induces the differentiation of the monocytic leukemia cell line M1 but suppresses the differentiation of totipotent embryonic stem cells. In an attempt to define the normal cellular targets for LIF, the distribution of LIF receptors within hemopoietic and hepatic tissue was analyzed by binding cells with radioiodinated LIF (125I-LIF) and subsequently carrying out autoradiography. Autoradiography demonstrated that in each hemopoietic tissue examined cells of monocyte/macrophage lineage were the primary cell type labeled with 125I-LIF. Moreover, both fetal and adult parenchymal hepatocytes displayed higher levels of labeling than either monocytes or macrophages. The number of receptors per positive cell varied from 150 for bone marrow monocytes to 2,000 for adult hepatocytes. In each case, however, binding was of high affinity, with an apparent KD of 34-100 pM, and binding was specific, since labeling was competed for by unlabeled LIF but not a range of other structurally unrelated growth and differentiation factors. It is suggested that LIF may play a role in regulating macrophage function and hepatic acute phase protein synthesis in response to infection.

Citing Articles

Molecular dynamics simulations reveal key roles of the LIF receptor in the assembly of human LIF signaling complex.

Gao B, Liu H, Zhu M, Zhang S, Wang M, Ruan Y Comput Struct Biotechnol J. 2025; 27:585-594.

PMID: 39989618 PMC: 11847480. DOI: 10.1016/j.csbj.2025.01.014.


Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma.

Liu R, Cui H, Li D, Guo X, Zhang Z, Tan S J Hepatocell Carcinoma. 2024; 11:2493-2504.

PMID: 39717509 PMC: 11665174. DOI: 10.2147/JHC.S500084.


Mechanism of sorafenib resistance associated with ferroptosis in HCC.

Guo L, Hu C, Yao M, Han G Front Pharmacol. 2023; 14:1207496.

PMID: 37351514 PMC: 10282186. DOI: 10.3389/fphar.2023.1207496.


An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.

Hunter S, McIntosh B, Shi Y, Parra Sperberg R, Funatogawa C, Labanieh L Commun Biol. 2021; 4(1):452.

PMID: 33846527 PMC: 8041770. DOI: 10.1038/s42003-021-01928-2.


Osteoblast and Osteoclast Activity Affect Bone Remodeling Upon Regulation by Mechanical Loading-Induced Leukemia Inhibitory Factor Expression in Osteocytes.

Du J, Yang J, He Z, Cui J, Yang Y, Xu M Front Mol Biosci. 2020; 7:585056.

PMID: 33324677 PMC: 7726425. DOI: 10.3389/fmolb.2020.585056.